Biocon Quarterly Results for Trading Insights

BIOCON • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹133 Cr
QSept 2025
Quarterly Results

Biocon Quarterly Results Key Highlights

  • Revenue of ₹4,356 Cr in Sept 2025 (-1.3% vs Mar 2025, +20.9% vs Sept 2024)
  • Net Profit of ₹133 Cr in Sept 2025 (-71.0% vs Mar 2025, +392.6% vs Sept 2024)
  • EBITDA of ₹884 Cr in Sept 2025 (-17.9% vs Mar 2025)
  • Operating Margin of 19.0% in Sept 2025 (-4.0pp vs Mar 2025)
  • Earnings Per Share of ₹0.66 in Sept 2025 (-77.1% vs Mar 2025)

Biocon Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 4,356 4,415 3,990 4,240 3,604 -1.3% 20.9%
Net Profit (₹ Cr) 133 459 89 -52 27 - -
EBITDA (₹ Cr) 884 1,077 797 607 699 - -
EPS (₹) 0.66 2.88 0.26 1.08 -0.13 - -
Operating Margin (%) 19.0% 23.0% 18.0% 12.0% 18.0% - -

Biocon Share Price Trend Around Quarterly Results

Visualize Biocon's 1-year price movement across quarterly results — ideal for logging trades in Biocon share price chart using Tickjournal. All values in ₹.

Related Pages for Biocon

Additional stock information and data for BIOCON

BIOCON share price history
BIOCON DCF
Biocon market worth
BIOCON price book multiple
Biocon P/E valuation
BIOCON ownership pattern
Biocon dividend policy

Profitability Ratios

Profit Margin 3.1%
EBITDA Margin 20.3%
Operating Margin 19.0%
ROE (Annual) 1.9%

Balance Sheet Highlights

Total Assets ₹58,797 Cr
Total Equity ₹27,713 Cr
Current Assets ₹16,286 Cr
Current Liabilities ₹16,751 Cr

Cash Flow Analysis

Operating Cash Flow ₹4,061 Cr
Investing Cash Flow ₹-203 Cr
Financing Cash Flow ₹-1,854 Cr
Net Cash Flow ₹2,004 Cr

Current Market Data

Current Price ₹383.55
Exchange NSE
Last Updated Mar 13, 2026

Revenue Trend (₹ Cr)

Dec 2025 4,240
Jun 2025 3,990
Mar 2025 4,415
Sept 2025 4,356

Net Profit Trend (₹ Cr)

Dec 2025 -52
Jun 2025 89
Mar 2025 459
Sept 2025 133

Operating Margin Trend (%)

Dec 2025 12.0%
Jun 2025 18.0%
Mar 2025 23.0%
Sept 2025 19.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Biocon quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹432,264.19 Cr 1801.6 14,875 3,125 +10.8% - 21.0% 138.6
Divis Laboratories
Sept 2025 		₹161,165.97 Cr 6071.0 2,860 689 +7.1% - 24.1% 233.8
Torrent Pharmaceuti…
Sept 2025 		₹148,577.55 Cr 4390.0 3,219 591 +11.3% - 18.4% 250.3
Dr Reddys Laborator…
Sept 2025 		₹107,859.28 Cr 1292.3 9,135 1,337 +1.1% - 14.6% 79.9
Cipla
Sept 2025 		₹107,029.80 Cr 1314.7 7,716 1,353 +12.0% - 17.5% 78.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores